Trials / Conditions / Stage IVC Major Salivary Gland Cancer AJCC v7
Stage IVC Major Salivary Gland Cancer AJCC v7
4 registered clinical trials studyying Stage IVC Major Salivary Gland Cancer AJCC v7.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma NCT01604772 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer NCT01254617 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma NCT01175980 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squam NCT00588770 | National Cancer Institute (NCI) | Phase 3 |